Cargando…

Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?

Detalles Bibliográficos
Autores principales:	Agarwal, Ritesh, Muthu, Valliappan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381185/ https://www.ncbi.nlm.nih.gov/pubmed/33583906 http://dx.doi.org/10.2169/internalmedicine.6807-20

Ejemplares similares

Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?”
por: Matsuura, Hiroaki, et al.
Publicado: (2021)

Fungal bronchitis or allergic bronchopulmonary aspergillosis …that is the question
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2021)

Allergic bronchopulmonary aspergillosis or pulmonary tuberculosis: A case of mistaken identity?
por: Muthu, Valliappan, et al.
Publicado: (2015)

Corticosteroids for Non-severe COVID-19: Primum Non Nocere
por: Muthu, Valliappan, et al.
Publicado: (2022)

Barrier enclosure device: One size does not fit all
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2021)

An unusual cause of massive hemoptysis: The demise of clinical history and a teachable moment from a fatal case
por: Chhabria, Bharath, et al.
Publicado: (2019)

Barrier Protection during Airway Intubation
por: Sehgal, Inderpaul S, et al.
Publicado: (2020)

Rare cause of spontaneous subcutaneous emphysema
por: Muthu, Valliappan, et al.
Publicado: (2016)

Removal of an inadvertently deployed self-expanding metallic Y stent
por: Muthu, Valliappan, et al.
Publicado: (2017)

Postbronchodilator lung function improvements with benralizumab for patients with severe asthma
por: Mathur, Sameer K., et al.
Publicado: (2020)

Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab
por: van der Veer, Tjeerd, et al.
Publicado: (2021)

The Reversed Halo Sign and the Bronchus Sign: The Eyes See Only What the Mind Knows
por: Muthu, Valliappan, et al.
Publicado: (2019)

Is bronchial thermoplasty safe in allergic bronchopulmonary aspergillosis or severe asthma with fungal sensitization?
por: Muthu, Valliappan, et al.
Publicado: (2021)

Tuberculosis or not tuberculosis: Attente cogitanti
por: Muthu, Valliappan, et al.
Publicado: (2020)

Where there is a balloon, there is a way!
por: Muthu, Valliappan, et al.
Publicado: (2020)

Covid‐19 in the absence of eosinophils: The outcome of confirmed SARS‐COV‐2 infection whilst on treatment with benralizumab
por: Francis, Charles H. R., et al.
Publicado: (2022)

Review of current and future therapeutics in ABPA
por: Lewington-Gower, Elisa, et al.
Publicado: (2021)

Bronchial asthma with ABPA presenting as PTE
por: Azad, Chandrika, et al.
Publicado: (2013)

Emergence of extrathoracic manifestations of eosinophilic granulomatosis with polyangiitis during benralizumab treatment
por: Lim, Andy K H, et al.
Publicado: (2021)

Feasibility of tele-follow-up of chronic respiratory disease patients in a resource-limited setting of northern India during COVID-19 pandemic
por: Kathirvel, Soundappan, et al.
Publicado: (2021)

Agreement Between Forced Expiratory Volume in the First Second (FEV(1)) and Peak Expiratory Flow (PEF) in Severe Acute Asthma
por: Damaraju, Vikram, et al.
Publicado: (2022)

An unusual cause of posterior mediastinal cyst
por: Dhooria, Sahajal, et al.
Publicado: (2015)

COVID-19-Associated Pulmonary Mucormycosis: An Underdiagnosed Entity with High Mortality
por: Muthu, Valliappan, et al.
Publicado: (2022)

COVID-19, mucormycosis, and the cow: Damned lies!
por: Muthu, Valliappan, et al.
Publicado: (2023)

Barrier enclosure device to sample difficult to access lesions by endobronchial ultrasound during the pandemic
por: Rao, Harshith, et al.
Publicado: (2022)

Characteristics of subjects unable to perform even a single acceptable spirometry maneuver (ATS grade F) identified within a cohort of 10,193 subjects
por: Ram, Babu, et al.
Publicado: (2023)

A real-world evaluation of severe asthmatics referred for bronchial thermoplasty
por: Prasad, Kuruswamy Thurai, et al.
Publicado: (2022)

The Use of Targeted Monoclonal Antibodies in the Treatment of ABPA—A Case Series
por: O’Reilly, Aoife, et al.
Publicado: (2021)

Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
por: Ghassemian, Arian, et al.
Publicado: (2021)

Barrier enclosure device during patient preparation for flexible bronchoscopy
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on tuberculosis notifications in India
por: Aggarwal, Ashutosh Nath, et al.
Publicado: (2022)

Postoperative bronchopleural fistula: Does one size fit all?
por: Muthu, Valliappan, et al.
Publicado: (2020)

Is a treatment for pityriasis rosea really needed?
por: Ciccarese, Giulia, et al.
Publicado: (2016)

Basophil Activation Test With Aspergillus Molecules: The Case for ABPA
por: Michel, Moïse, et al.
Publicado: (2022)

Central airway obstruction due to endoluminal tumors: Experience from a tertiary care center in North India
por: Saxena, Puneet, et al.
Publicado: (2022)

Role of EBUS-TBNA in the Diagnosis of Tuberculosis and Sarcoidosis
por: Gupta, Nalini, et al.
Publicado: (2019)

Major complications encountered during 9979 flexible bronchoscopies performed under local anesthesia over 8 years
por: Muthu, Valliappan, et al.
Publicado: (2022)

Severe bleeding following biopsy of an isolated endobronchial ulcer
por: Muthu, Valliappan, et al.
Publicado: (2022)

Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
por: Nanzer, Alexandra M., et al.
Publicado: (2020)

Pulmonary actinomycosis and polymicrobial empyema in a patient with ABPA and bronchocoele
por: Tu, Jacky, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cl94k5afgcnj28jurin9b1cg4h